Investigational Drug Details
| Drug ID: | D522 |
| Drug Name: | Cicletanine |
| Synonyms: | |
| Type: | small molecule |
| DrugBank ID: | DB12766 |
| DrugBank Description: | Cicletanine is under investigation for the treatment of Diabetes, Hypokalemia, Hyponatremia, and Arterial Hypertension. |
| PubChem ID: | 54910 |
| CasNo: | 89943-82-8 |
| Repositioning for NAFLD: | Yes |
| SMILES: | CC1=C(O)C2=C(C=N1)C(OC2)C1=CC=C(Cl)C=C1 |
| Structure: |
|
| InChiKey: | CVKNDPRBJVBDSS-UHFFFAOYSA-N |
| Molecular Weight: | 261.71 |
| DrugBank Targets: | |
| DrugBank MoA: | |
| DrugBank Pharmacology: | |
| DrugBank Indication: | |
| Targets: | |
| Therapeutic Category: | |
| Clinical Trial Progress: | |
| Latest Progress: |
| Trial ID | Source ID | Phases | Status | Study Results | Start Date | Last Update Posted | |
|---|---|---|---|---|---|---|---|
| L4729 | NCT04660643 | PHASE3 | COMPLETED | YES | 2021-03-29 | 2024-05-22 | Details |
| Target ID | Target Name | GENE | Action | Class | UniProtKB ID | Entry Name |
|---|
| Strategy ID | Strategy | Synonyms | Related Targets | Related Drugs |
|---|
| Article ID | PMID | Source | Title |
|---|